Kimberly Blackwell, CEO, Director at Zentalis Pharmaceuticals, holds 484.14K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds ― shares in Century Therapeutics (Ticker: IPSC), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE).
Kimberly Blackwell latest transaction was an Uninformative Buy of ―.
What was Kimberly Blackwell's most profitable transaction?
Kimberly Blackwell’s most profitable transaction was an Informative Buy of ZNTL stock on November 13, 2023. The return on the trade was 14.10%.
What is Kimberly Blackwell's role in Zentalis Pharmaceuticals?
Kimberly Blackwell's role in Zentalis Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.